AMD_KOPRI research investigates the anti-inflammatory and anticancer molecular mechanisms of an ethanol extract from the Antarctic freshwater microalga Micractinium sp. (ETMI). The study employed in vitro assays using RAW 264.7 macrophages and HCT116 human colon cancer cells to measure dose-dependent effects on key indicators. The dataset contains results from these assays, including measurements of inflammatory markers and gene expression related to cell cycle arrest.
Use Cases
- Model dose-dependent cytotoxic activity against HCT116 cells using ETMI concentration as a feature.
- Predict changes in inflammatory marker levels (COX-2, IL-6, iNOS, TNF-α, NO) from ETMI treatment dosage.
- Analyze the relationship between ETMI concentration and transcriptional regulation of G1/S phase genes (CDKN1A, CDK4, CDK6).
- Correlate anti-inflammatory activity indicators with anticancer cell proliferation outcomes in a unified model.
Strengths
- Data is derived from controlled in vitro assays on two standardized cell lines (RAW 264.7 and HCT116).
- Study measures multiple specific molecular indicators (COX-2, IL-6, iNOS, TNF-α, NO, CDKN1A, CDK4, CDK6).
- Experimental design includes dose-dependent response measurements for both anti-inflammatory and cytotoxic activities.
Limitations
- Sample size (number of experimental replicates or data points) is not specified in the description.
- Dataset scope is limited to one microalgal species (Micractinium sp.) and one cancer cell line (HCT116).
- Temporal coverage of the experiments and data recency are unknown.
Provenance
- Source
- AMD_KOPRI (likely affiliated with the Korea Polar Research Institute), hosted on NASA Earthdata.
- Collection Method
- Data generated from laboratory in vitro assays on cell cultures, measuring molecular indicators and gene expression.
- Geography
- Source organism is the Antarctic freshwater microalga Micractinium sp.